Antonio Finelli
#154,961
Most Influential Person Now
Researcher
Antonio Finelli's AcademicInfluence.com Rankings
Antonio Finellicomputer-science Degrees
Computer Science
#8459
World Rank
#8892
Historical Rank
Computational Linguistics
#1887
World Rank
#1907
Historical Rank
Machine Learning
#3469
World Rank
#3512
Historical Rank
Artificial Intelligence
#3769
World Rank
#3824
Historical Rank
Download Badge
Computer Science
Antonio Finelli's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Antonio Finelli Influential?
(Suggest an Edit or Addition)Antonio Finelli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (509)
- Active surveillance of small renal masses: progression patterns of early stage kidney cancer. (2011) (438)
- Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. (2011) (361)
- Complications of laparoscopic partial nephrectomy in 200 cases. (2005) (299)
- Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. (2016) (293)
- Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. (2017) (232)
- Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience. (2015) (229)
- Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. (2008) (222)
- Rationale for percutaneous biopsy and histologic characterisation of renal tumours. (2012) (221)
- Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. (2013) (221)
- Influence of semen processing technique on human sperm DNA integrity. (2000) (190)
- ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging (2010) (175)
- Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking. (2017) (173)
- Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study. (2012) (173)
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (163)
- Landmarks in the diagnosis and treatment of renal cell carcinoma (2014) (163)
- Functional genomic landscape of cancer-intrinsic evasion of killing by T cells (2020) (160)
- International Urology Journal Club via Twitter: 12-month experience. (2014) (147)
- Laparoscopic radical nephrectomy for large (greater than 7 cm, T2) renal tumors. (2004) (140)
- Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. (2013) (137)
- Prospective, randomized comparison of transperitoneal versus retroperitoneal laparoscopic adrenalectomy. (2005) (137)
- Evidence for a biopsy derived grade artifact among larger prostate glands. (2006) (128)
- Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant. (2005) (125)
- Laparoscopic partial nephrectomy: 3-year followup. (2006) (121)
- Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. (2009) (117)
- Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline. (2018) (114)
- Clinical predictors of gleason score upgrading (2007) (109)
- Prospective, randomized comparison of transperitoneal versus retroperitoneal laparoscopic adrenalectomy. Commentary (2005) (106)
- Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. (2004) (103)
- Complications of laparoscopic surgery for renal masses: prevention, management, and comparison with the open experience. (2009) (103)
- Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. (2010) (101)
- Laparoscopic partial nephrectomy in solitary kidney. (2006) (101)
- Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy. (2016) (101)
- Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome (2012) (100)
- Endoscopic lymphadenectomy for penile carcinoma. (2007) (98)
- Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates. (2015) (98)
- Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort. (2015) (97)
- The Hem-o-lok clip is safe for laparoscopic nephrectomy: a multi-institutional review. (2008) (95)
- Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma. (2016) (93)
- Tumor Suppressor microRNAs, miR-100 and -125b, Are Regulated by 1,25-dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue (2013) (90)
- Optimal Management of High-Risk T1G3 Bladder Cancer: A Decision Analysis (2007) (89)
- Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement. (2014) (89)
- The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC). (2015) (88)
- Active Surveillance for Renal Neoplasms with Oncocytic Features is Safe. (2016) (85)
- Impact of positive surgical margins after radical prostatectomy differs by disease risk group. (2010) (85)
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (83)
- Lateral pedicle control during laparoscopic radical prostatectomy: refined technique. (2005) (76)
- Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients. (2013) (76)
- Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinoma. (2005) (75)
- Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial. (2007) (75)
- Laparoscopic repair of vesicovaginal fistula. (2005) (72)
- Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial. (2021) (70)
- A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer (2014) (70)
- Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population‐based study (2013) (68)
- Staging and Staging Errors in Bladder Cancer (2010) (67)
- Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance. (2011) (66)
- Prehabilitation for radical prostatectomy: A multicentre randomized controlled trial. (2018) (66)
- Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort (2011) (65)
- Cost‐effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette‐Guerin therapy for high‐risk, high‐grade (T1G3) bladder cancer (2009) (63)
- Laparoscopic radical cystectomy in the female. (2005) (63)
- Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf model. (2005) (62)
- Water jet assisted laparoscopic partial nephrectomy without hilar clamping in the calf model. (2005) (59)
- Imaging renal cell carcinoma with ultrasonography, CT and MRI (2010) (58)
- Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly. (2014) (57)
- Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry (2017) (57)
- Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance (2017) (56)
- Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer. (2011) (56)
- Results of a national population-based study of outcomes of surgery for renal tumors associated with inferior vena cava thrombus. (2013) (55)
- Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes. (2016) (54)
- Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses? (2018) (54)
- Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men. (2014) (54)
- First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. (2018) (52)
- Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis. (2017) (51)
- Measurement of peri‐prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer (2012) (51)
- Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer. (2011) (51)
- Accuracy of Contrast-enhanced US for Differentiating Benign from Malignant Solid Small Renal Masses. (2015) (51)
- Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer. (2011) (50)
- Cryotherapy and radiofrequency ablation: pathophysiologic basis and laboratory studies (2003) (50)
- Laparoscopic partial nephrectomy: contemporary technique and results. (2004) (48)
- Lean methodology improves efficiency in outpatient academic uro-oncology clinics. (2014) (46)
- Robotic surgery basic skills training: Evaluation of a pilot multidisciplinary simulation-based curriculum. (2013) (45)
- Pathological, oncologic and functional outcomes of radical prostatectomy following active surveillance. (2013) (45)
- Canadian guidelines for the management of small renal masses (SRM). (2015) (45)
- Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies (2010) (45)
- Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada. (2014) (44)
- The REDUCE trial: chemoprevention in prostate cancer using a dual 5α-reductase inhibitor, dutasteride (2008) (44)
- Prehabilitation for men undergoing radical prostatectomy: a multi-centre, pilot randomized controlled trial (2014) (43)
- Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients. (2011) (42)
- Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy. (2009) (42)
- Canadian Urological Association recommendations on prostate cancer screening and early diagnosis (2017) (40)
- Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. (2020) (40)
- How does context influence collaborative decision-making for health services planning, delivery and evaluation? (2014) (40)
- Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma. (2013) (40)
- Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature. (2006) (39)
- Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline. (2020) (38)
- A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression. (2014) (38)
- Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review. (2016) (38)
- Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance (2017) (38)
- Laparoscopic cytoreductive nephrectomy for metastatic renal cell carcinoma (2004) (38)
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. (2020) (38)
- The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future (2020) (37)
- Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis. (2017) (37)
- Does patient age affect survival after radical cystectomy? (2012) (37)
- Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. (2021) (36)
- Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma (2018) (36)
- Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care - Cancer Care Ontario Clinical Practice Guideline. (2017) (36)
- The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System. (2016) (35)
- Small (≤4 cm) cortical renal tumors: characterization with multidetector CT (2010) (35)
- Structured electronic operative reporting: Comparison with dictation in kidney cancer surgery (2012) (35)
- Long‐term follow‐up of T1 high‐grade bladder cancer after intravesical bacille Calmette‐Guérin treatment (2011) (35)
- Laparoscopic repair of rectourethral fistulas after prostate surgery. (2007) (34)
- A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy (2016) (34)
- Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue (2012) (33)
- Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study (2013) (33)
- Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes (2018) (33)
- Volume-outcome relationships in the treatment of renal tumors. (2012) (33)
- Laparoscopic rectovesical fistula repair. (2005) (33)
- Renal tumor biopsy: indicators, technique, safety, accuracy results, and impact on treatment decision management (2018) (33)
- Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols (2013) (32)
- The effect of age on the morbidity of kidney surgery. (2011) (31)
- The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder. (2015) (31)
- Laparoscopic heminephrectomy for tumor. (2005) (31)
- Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end‐stage renal disease (ESRD) (2015) (31)
- The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis (2017) (30)
- Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect (2018) (29)
- Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline Summary. (2017) (28)
- Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer. (2016) (28)
- Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer (2019) (28)
- Nerve-sparing laparoscopic radical cystectomy: technique and initial outcomes. (2006) (28)
- A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol (2015) (28)
- Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer. (2019) (27)
- Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort. (2014) (27)
- Outpatient laparoscopic pyeloplasty. (2005) (27)
- Nephroureterostomy-drained percutaneous nephrolithotomy: modification combining safety with decreased morbidity. (2004) (26)
- Enhancement Threshold of Small (< 4 cm) Solid Renal Masses on CT. (2016) (26)
- Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy. (2016) (26)
- Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer (2012) (26)
- Stricter Active Surveillance Criteria for Prostate Cancer do Not Result in Significantly Better Outcomes: A Comparison of Contemporary Protocols. (2016) (26)
- Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified. (2016) (26)
- miR-10b is a prognostic marker in clear cell renal cell carcinoma (2017) (25)
- Diminished efficacy of Bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer. (2011) (25)
- Active Surveillance in Small Renal Masses in the Elderly: A Literature Review. (2017) (25)
- Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer – phase 1 trial (2018) (25)
- The Bladder Utility Symptom Scale: A Novel Patient Reported Outcome Instrument for Bladder Cancer (2018) (24)
- Impact of 5-alpha reductase inhibitors on men followed by active surveillance for prostate cancer: a time-dependent covariate reanalysis. (2013) (24)
- Expanding the indications for laparoscopic radical nephrectomy (2007) (24)
- Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma (2016) (23)
- Comparison of MRI- and TRUS-Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy-Naive Men: A Systematic Review and Meta-Analysis. (2020) (23)
- Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine (2016) (23)
- CUA guideline on the management of cystic renal lesions. (2017) (23)
- Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative. (2017) (23)
- Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature. (2021) (22)
- Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study. (2016) (22)
- Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses. (2018) (22)
- The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study. (2017) (22)
- What is the best treatment strategy for incidentally detected small renal masses? A decision analysis (2011) (22)
- An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathways (2015) (22)
- Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design. (2015) (21)
- The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy. (2014) (21)
- Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors. (2010) (21)
- Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines (2017) (21)
- Incident Cancer Detection During the COVID-19 Pandemic. (2022) (21)
- Chronic kidney disease in patients with renal cell carcinoma. (2014) (21)
- Development and external validation of a biopsy‐derived nomogram to predict risk of ipsilateral extraprostatic extension (2017) (20)
- Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma. (2015) (20)
- A Canadian framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the Canadian Urologic Oncology Group and the Canadian Urological Association. (2020) (20)
- Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis (2017) (20)
- Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2. (2019) (20)
- Conceptualizing global health-related quality of life in bladder cancer (2014) (19)
- Physician Self‐Audit: A Scoping Review (2011) (19)
- CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update. (2013) (19)
- The uptake of active surveillance for the management of prostate cancer: A population-based analysis. (2016) (19)
- Searching for prognostic biomarkers for small renal masses in the urinary proteome (2020) (18)
- MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. (2021) (18)
- Perineural invasion on prostate biopsy does not predict adverse pathological outcome. (2012) (18)
- International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy (2019) (17)
- Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline. (2016) (17)
- How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population‐based analysis (2011) (17)
- Salvage radical prostatectomy following focal therapy: functional and oncological outcomes (2019) (17)
- Do we continue to unnecessarily perform ipsilateral adrenalectomy at the time of radical nephrectomy? A population based study. (2011) (17)
- Surveillance of Small Renal Masses. (2016) (17)
- The true risk of blood transfusion after nephrectomy for renal masses: a population‐based study (2013) (17)
- Downgrading of biopsy based Gleason score in prostatectomy specimens (2013) (17)
- The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis. (2016) (17)
- 554 Initial Results of Mr Guided Laser Focal Therapy for Prostate Cancer (2013) (16)
- Laparoscopic partial nephrectomy in the presence of multiple renal arteries. (2007) (16)
- Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer. (2021) (16)
- A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization (2017) (15)
- Re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol 2016;70:403-6. (2017) (15)
- Oncologic outcomes following radical prostatectomy in the active surveillance era. (2013) (15)
- The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy. (2018) (15)
- Prognostic Urinary miRNAs for the Assessment of Small Renal Masses. (2019) (15)
- Effect of healthcare provider characteristics on nodal yield at radical cystectomy. (2008) (15)
- An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further Followup. (2016) (15)
- Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ-cell tumors: current status. (2007) (14)
- Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer (2015) (14)
- Impact of Abiraterone Acetate and Enzalutamide on Symptom Burden of Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer. (2017) (14)
- S100A11 is a potential prognostic marker for clear cell renal cell carcinoma (2015) (14)
- Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: observations on DNA, RNA, protein extractions and VHL mutation detection. (2012) (14)
- Management of kidney cancer: canadian kidney cancer forum consensus update 2011. (2012) (14)
- Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study (2017) (14)
- Statin use and kidney cancer outcomes: A propensity score analysis. (2016) (14)
- Randomized Clinical Trial of Vitamin D 3 Doses on Prostatic Vitamin D Metabolite Levels and Ki 67 Labeling in Prostate Cancer Patients (2013) (14)
- Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass. (2020) (14)
- Predictors of early mortality after radical nephrectomy with renal vein or inferior vena cava thrombectomy – a population‐based study (2012) (14)
- Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology? (2014) (13)
- ACTIVE SURVEILLANCE OF SMALL RENAL MASSES: A PROSPECTIVE MULTI-CENTER CANADIAN URO-ONCOLOGY GROUP TRIAL (2009) (13)
- Examining risk perception among men with a family history of prostate cancer. (2011) (13)
- Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma. (2018) (13)
- Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center. (2011) (13)
- Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights. (2015) (13)
- Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience. (2020) (13)
- Active surveillance in patients with a PSA >10 ng/mL. (2014) (13)
- A Prospective Randomized Controlled Trial of Irrigation "Bag Squeeze" to Manage Pain for Patients Undergoing Flexible Cystoscopy. (2020) (12)
- A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. (2020) (12)
- Psychological distress and lifestyle disruption in low-risk prostate cancer patients: Comparison between active surveillance and radical prostatectomy (2018) (12)
- A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. (2021) (12)
- Surgical wait times for patients with urological cancers: a survey of Canadian surgeons. (2006) (12)
- Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (11)
- Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial. (2022) (11)
- Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum. (2019) (11)
- Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy (2018) (11)
- Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival (2013) (11)
- Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatment. (2018) (11)
- Should follow-up biopsies for men on active surveillance for prostate cancer be restricted to limited templates? (2013) (11)
- Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass. (2019) (11)
- Point-of-care clinical documentation: assessment of a bladder cancer informatics tool (eCancerCareBladder): a randomized controlled study of efficacy, efficiency and user friendliness compared with standard electronic medical records (2011) (11)
- Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes. (2019) (11)
- Medication use and kidney cancer risk: A population-based study. (2017) (11)
- The long-term outcomes of Gleason grade groups 2 and 3 prostate cancer managed by active surveillance: Results from a large population-based cohort. (2020) (10)
- Systematic review of clinical features of suspected prostate cancer in primary care. (2015) (10)
- Impact of Time-To-Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma. (2019) (10)
- Management of small renal mass: an opportunity to address a growing problem in early stage kidney cancer. (2015) (10)
- 2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC). (2021) (10)
- Diabetes and kidney cancer outcomes: a propensity score analysis (2017) (10)
- Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population. (2020) (10)
- Association between metformin medication, genetic variation and prostate cancer risk (2020) (10)
- Pfilates and Hypopressives for the Treatment of Urinary Incontinence After Radical Prostatectomy: Results of a Feasibility Randomized Controlled Trial (2020) (10)
- Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline. (2017) (10)
- Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort. (2017) (10)
- Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse (2021) (9)
- Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not (2020) (9)
- Laparoscopic partial nephrectomy for cancer: techniques and outcomes. (2005) (9)
- A population-based study of surgeon characteristics associated with the uptake of contemporary techniques in renal surgery. (2013) (9)
- 2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC). (2019) (9)
- Critical appraisal of the application of propensity score methods in the urology literature (2017) (9)
- Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort (2021) (9)
- Does nerve-sparing radical prostatectomy increase the risk of positive surgical margins and biochemical progression? (2010) (9)
- The use of magnetic resonance imaging in the diagnosis and followup of pediatric pelvic rhabdomyosarcoma. (2000) (9)
- An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer. (2018) (8)
- Baseline Laparoscopic Skill May Predict Baseline Robotic Skill and Early Robotic Surgery Learning Curve. (2016) (8)
- Statin use and time to progression in men on active surveillance for prostate cancer (2018) (8)
- Management of men with previous negative prostate biopsy (2016) (8)
- ACTIVE SURVEILLANCE OF SMALL RENAL MASSES: A PROSPECTIVE MULTI-CENTRE CANADIAN TRIAL (2008) (8)
- Preoperative Brimonidine Tartrate 0.2% Does not Prevent an Intraocular Pressure Rise During Prostatectomy in Steep Trendelenburg Position (2018) (8)
- Describing perspectives of health care professionals on active surveillance for the management of prostate cancer (2018) (8)
- Kidney cancer: Routine small renal mass needle biopsy should be adopted (2014) (8)
- Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancer. (2018) (8)
- Adult Urology Laparoscopic Repair of Rectourethral Fistulas After Prostate Surgery (2010) (8)
- Health-related quality of life in robotic versus open radical prostatectomy. (2015) (8)
- Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapy. (2012) (8)
- Should Prebiopsy Multiparametric Magnetic Resonance Imaging be Offered to All Biopsy-naïve Men Undergoing Prostate Biopsy? (2016) (7)
- Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression. (2014) (7)
- Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy (2016) (7)
- How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis (2011) (7)
- Causal Mediation Analysis for Standardized Mortality Ratios. (2019) (7)
- Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis (2019) (7)
- Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinoma (2020) (7)
- Critique of laparoscopic lymphadenectomy in genitourinary oncology. (2004) (7)
- 1951: Laparoscopic Living Donor Nephrectomy in Patients with Multiple Renal Arteries or Anomalous Renal Veins (2004) (7)
- Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective. (2017) (7)
- Medication use and kidney cancer survival: A population‐based study (2018) (7)
- Final results of a phase II study of neoadjuvant metformin in prostatic carcinoma. (2013) (7)
- Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: long-term oncologic outcomes (2008) (7)
- Genetic factors associated with prostate cancer conversion from active surveillance to treatment (2021) (7)
- Renal Function Outcomes Following Radical or Partial Nephrectomy for Localized Renal Cell Carcinoma: Should Urologists Rely on Preoperative Variables to Predict Renal Function in the Long Term? (2019) (7)
- The emerging role of percutaneous biopsy in diagnosis and management of small renal masses (2012) (6)
- Natural History of Renal Angiomyolipoma Favors Surveillance as an Initial Approach. (2020) (6)
- Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives. (2018) (6)
- A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes. (2019) (6)
- What are the limits of focal therapy for localized prostate cancer? For: GG3-5 may be considered. (2020) (6)
- 5-Alpha reductase inhibitors in active surveillance (2014) (6)
- Canadian Men’s perspectives about active surveillance in prostate cancer: need for guidance and resources (2017) (6)
- Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer (2014) (6)
- Active surveillance failure for prostate cancer: does the delay in treatment increase the risk of urinary incontinence? (2012) (6)
- Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy (2022) (6)
- A Canadian consensus forum on the management of patients with advanced prostate cancer. (2019) (6)
- 821 SMALL RENAL MASS NEEDLE CORE BIOPSY: OUTCOMES OF NON-DIAGNOSTIC PERCUTANEOUS BIOPSY AND ROLE OF REPEAT BIOPSY (2010) (6)
- Needle Tract Seeding Following Renal Tumor Biopsy: Scarcely a Concern or a Concern to Scare? (2019) (6)
- An efficient solution to the retained Foley catheter. (2006) (6)
- Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes? (2020) (6)
- Magnetic resonance imaging diagnosis of prostate cancer: promise and caution (2019) (5)
- 509: The Natural History of Small Renal Masses: A Prospective Multi-Center Canadian Trial (2007) (5)
- Predictive Value of In Vivo MR Spectroscopy With Semilocalization by Adiabatic Selective Refocusing in Differentiating Clear Cell Renal Cell Carcinoma From Other Subtypes. (2020) (5)
- UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging. (2022) (5)
- Does Time Spent on Active Surveillance Adversely Affect the Pathologic and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy? (2019) (5)
- Establishing a global quality of care benchmark report (2021) (5)
- Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. (2021) (5)
- Primary analysis of a phase II study of metastasis-directed ablative therapy to PSMA (18F-DCFPyL) PET-MR/CT defined oligorecurrent prostate cancer. (2020) (5)
- The value of complementing administrative data with abstracted information on smoking and obesity: A study in kidney cancer. (2017) (5)
- [18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial (2020) (5)
- 1595 EXTENDED LYMPHADENECTOMY AND CHEMOTHERAPY OFFER SURVIVAL ADVANTAGE IN MUSCLE-INVASIVE BLADDER CANCER (2011) (5)
- Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer. (2022) (5)
- Factors Associated With Discontinuation of Active Surveillance among Men With Low-Risk Prostate Cancer: A Population-Based Study. (2021) (5)
- 1308 PARTIAL NEPHRECTOMY FOR THE TREATMENT OF RENAL CELL CARCINOMA AND THE RISK OF END STAGE RENAL DISEASE (2013) (5)
- Associations between self‐reported physical activity, quality of life, and emotional well‐being in men with prostate cancer on active surveillance (2020) (5)
- Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases (2019) (5)
- Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. (2022) (5)
- Testosterone Responders to Continuous Androgen Deprivation Therapy Show Considerable Variations in Testosterone Levels on Followup: Implications for Clinical Practice (2018) (4)
- Management of complex renal cysts in Canada: results of a survey study (2020) (4)
- Virtual care for prostate cancer survivorship: protocol for an evaluation of a nurse-led algorithm-enhanced virtual clinic implemented at five cancer centres across Canada (2021) (4)
- Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity (2021) (4)
- Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence? (2020) (4)
- Positive surgical margins after partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer Information System database. (2014) (4)
- The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy. (2014) (4)
- Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol (2019) (4)
- MP53-12 THE ROLE OF PROSTATE CANCER ANTIGEN 3 (PCA3) TEST AND MULTI-PARAMETRIC PROSTATIC MAGNETIC RESONANCE IMAGING (MPMRI) AMONG PATIENTS WITH PRIOR NEGATIVE BIOPSY: CORRELATION WITH RADICAL PROSTATECTOMY PATHOLOGY (2016) (4)
- 1649: Complications of Laparoscopic Partial Nephrectomy in 200 Patients (2004) (4)
- High-intensity interval training or resistance training versus usual care in men with prostate cancer on active surveillance: A three-arm feasibility randomized controlled trial. (2021) (4)
- Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer. (2019) (4)
- Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer. (2021) (4)
- Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detection. (2008) (4)
- Guideline for referral of patients with suspected prostate cancer by family physicians and other primary care providers. (2015) (4)
- Creating patient-centered radiology reports to empower patients undergoing prostate magnetic resonance imaging. (2020) (3)
- Randomized phase II trial of neoadjuvant abiraterone plus or minus cabazitaxel in high-risk prostate cancer: ACDC-RP. (2022) (3)
- 2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC). (2019) (3)
- Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302. (2018) (3)
- Methylation markers in prostate biopsies are prognosticators for late biochemical recurrence and therapy after surgery in prostate cancer patients. (2019) (3)
- National consensus quality indicators to assess quality of care for active surveillance in low-risk prostate cancer: An evidence-informed modified Delphi survey of Canadian urologists/radiation oncologists. (2021) (3)
- 1298: Laparoscopic Partial Nephrectomy in the Presence of Multiple Renal Vessels (2004) (3)
- The association between physician trust and prostate specific antigen screening: Implications for shared decision making. (2018) (3)
- Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer (2020) (3)
- Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate Cancer. (2017) (3)
- MP31-17 VALIDATING THE BLADDER UTILITY SYMPTOM SCALE (BUSS): A NOVEL PATIENT REPORTED OUTCOME QUALITY OF LIFE MEASURE FOR ALL PATIENTS WITH BLADDER CANCER (2016) (3)
- Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists. (2020) (3)
- What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy? (2017) (3)
- Testing the evolution process of prostate‐specific antigen in early stage prostate cancer: what is the proper underlying model? (2011) (3)
- A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide. (2021) (3)
- Association between metformin medication, genetic variation and prostate cancer risk (2020) (3)
- Causal Mediation Analysis for Standardized Mortality Ratios. (2019) (3)
- 1665 THE EFFECT OF AGE ON THE MORBIDITY OF KIDNEY SURGERY IN GENERAL CLINICAL PRACTICE (2011) (3)
- Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers. (2021) (3)
- Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapy. (2009) (3)
- Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (3)
- Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma (2022) (3)
- An online Sexual Health and Rehabilitation eClinic (TrueNTH SHAReClinic) for prostate cancer patients: a feasibility study (2021) (3)
- Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large Canadian multi-institutional database. (2019) (3)
- Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion. (2017) (3)
- Quantifying the "Assistant Effect" in Robotic-Assisted Radical Prostatectomy (RARP): Measures of Technical Performance. (2020) (3)
- Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. (2023) (3)
- A novel predictor of clinical progression in patients on active surveillance for prostate cancer. (2019) (3)
- Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis (2019) (3)
- Achieving the “trifecta” with open versus minimally invasive partial nephrectomy (2020) (3)
- Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study. (2020) (3)
- Natural history of untreated kidney cancer (2021) (3)
- Cost of illness of renal cell carcinoma in Canada (2007) (3)
- Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis. (2019) (3)
- Extended Results and Independent Validation of a Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer. (2022) (3)
- Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study (2021) (3)
- Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer (2019) (3)
- Cost effectiveness of sorafenib versus best supportive care in advanced renal cell carcinoma in Canada (2007) (3)
- Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (3)
- Negative predictive value of prostate multi-parametric magnetic resonance imaging among men with negative prostate biopsy and elevated PSA - a clinical outcome retrospective cohort study. (2019) (2)
- MP01-18 QUANTIFYING THE ‘ASSISTANT EFFECT’ IN ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: MEASURES OF TECHNICAL PERFORMANCE (2018) (2)
- Risk perception and psychological morbidity in men at elevated risk for prostate cancer. (2015) (2)
- Canadian Urological Association guideline: Management of small renal masses - Full-text. (2022) (2)
- Essential experimental steps and estimates of renal carcinoma initiating cells. (2014) (2)
- 166 IS FEMALE GENDER A RISK FACTOR FOR ABSENT DETRUSOR MUSCLE AT TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) (2010) (2)
- Impact of multiparametric endorectal coil prostate MRI on disease reclassification among active surveillance candidates: A prospective cohort study. (2012) (2)
- A narrative review and update on management following negative prostate biopsy (2018) (2)
- Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic? (2022) (2)
- MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. (2021) (2)
- V935: Laparoscopic Pyelolithotomy for Staghorn Stones (2006) (2)
- Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers. (2021) (2)
- PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma (2022) (2)
- 1288: Hydrojet-Assisted Laparoscopic Partial Nephrectomy: Feasibility Study (2004) (2)
- UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes. (2022) (2)
- Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification (2022) (2)
- The impact of introducing laparoscopic radical prostatectomy on surgical wait times for prostate cancer. (2006) (2)
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (2)
- Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum. (2020) (2)
- A stochastic approach to risk management for prostate cancer patients on active surveillance. (2011) (2)
- Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis. (2021) (2)
- Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada (2020) (2)
- Canadian Update on Surgical Procedures (CUSP) Urology Group consensus for intraoperative hemostasis during minimally invasive partial nephrectomy. (2020) (2)
- Renal biopsies for small renal masses. For whom, when and how. (2013) (2)
- Challenges Interpreting Chemoprevention Studies Using Observational Data. (2017) (2)
- Assessing the Impact of the COVID-19 Pandemic on Emergency Department Use for Patients Undergoing Cancer-Directed Surgeries (2022) (2)
- Defining a cohort of men who may not require repeat prostate biopsy based on PCA3 and MRI: The double negative effect (2017) (2)
- Causal variance decompositions for institutional comparisons in healthcare (2019) (2)
- Treatment on active surveillance of small renal masses: Progression vs. preference. (2021) (2)
- Impact of a novel prioritization framework on clinician-led oncology drug submissions. (2019) (2)
- Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled Trial. (2020) (2)
- V1150: Robotic-Assisted Laparoscopic Retroperitoneal Pyeloplasty (2005) (2)
- VHL-mutant renal cell carcinomas contain cancer cells with mesenchymal phenotypes. (2013) (2)
- Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells. (2019) (2)
- Functional genomic landscape of cancer-intrinsic evasion of killing by T cells (2020) (2)
- Hematologic Parameters to Predict Small Renal Mass Biopsy Pathology. (2016) (2)
- 1748: Laparoscopic Heminephrectomy for Renal Tumors (2004) (2)
- Comparing Perspectives of Canadian Men Diagnosed With Prostate Cancer and Health Care Professionals About Active Surveillance (2020) (2)
- Abstract LB-435: Double-blind randomized clinical trial of vitamin D3 showing effects on tissue calcitriol levels, gene expression and proliferation immunohistochemistry in prostate cancer (2012) (2)
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy. (2014) (2)
- A systematic review and meta-analysis of unplanned hospital visits and re-admissions following radical prostatectomy for prostate cancer. (2021) (2)
- MP75-09 THE NATURAL HISTORY OF RENAL FUNCTION AFTER SURGICAL MANAGEMENT OF RENAL CELL CARCINOMA: RESULTS FROM THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM (2016) (2)
- Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 Years (2018) (2)
- Real world patterns of treatment sequencing in Canada for metastatic castrate-resistant prostate cancer. (2018) (2)
- Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in Canada (2023) (2)
- Low Testosterone and Prostate Cancer: Is the Protection Real? (2018) (2)
- Symptom experiences of older adults undergoing treatment for metastatic castrate-resistant prostate cancer (2021) (2)
- Abstract CT-04: A phase II study of neoadjuvant metformin in prostatic carcinoma (2012) (2)
- 623 Validating the Bladder Utility Symptom Scale (BUSS): A multi attribute health state classification system for bladder cancer (2016) (2)
- Evolving real-world patterns of practice in metastatic castration-sensitive prostate cancer (mCSPC): The genitourinary research consortium (GURC) national multicenter cohort study. (2022) (2)
- The rising burden of acute urological disease at an urban, academic hospital network. (2022) (1)
- The effect of lifestyle changes on serum PSA levels in a cohort of asymptomatic men with PSA between 2-10 ng/ml and normal DRE (2019) (1)
- PD27-10 SURGICAL PERFORMANCE AS A PREDICTOR OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES IN ROBOTIC PROSTATECTOMY (2019) (1)
- 1364 HOW OFTEN ARE PATIENTS WITH DIABETES OR HYPERTENSION BEING TREATED WITH PARTIAL NEPHRECTOMY FOR RCC? A POPULATION-BASED ANALYSIS (2010) (1)
- Uncoupling Diagnosis and Treatment of Incidentally Imaged Renal Masses. (2018) (1)
- MP85-10 PROSTATE CANCER REHABILITATION: OUTCOMES OF A SEXUAL HEALTH CLINIC (2018) (1)
- Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study. (2017) (1)
- Opioid Use after Nephrectomy for Kidney Cancer in Ontario: A Population-Based Study. (2022) (1)
- Seminar article Laparoscopic partial nephrectomy: contemporary technique and results (2004) (1)
- Psychological Distress in Older Adults During Treatment for Advanced Prostate Cancer (2021) (1)
- MP4-05 USE OF INITIAL ACTIVE SURVEILLANCE AMONG MEN WITH LOW-RISK PROSTATE CANCER – FOLLOW UP AND FALL OUT (2015) (1)
- 570: Cost Effectiveness of Treatment Strategies for High Risk T1G3 Bladder Cancer (2007) (1)
- TESTOSTERONE RESPONDERS TO CONTINUOUS ANDROGEN DEPRIVATION THERAPY EXHIBIT CONSIDERABLE VARIATION IN TESTOSTERONE LEVELS ON FOLLOW UP: PD24‐08 (2017) (1)
- Androgen deprivation therapy for prostate cancer: Prescribing behaviors and preferences among urologists. (2022) (1)
- Web-Based Peer Navigation for Men with Prostate Cancer and Their Family Caregivers: A Pilot Feasibility Study (2022) (1)
- THE MORBIDITY OF RENAL SURGERY: DATA FROM A POPULATION-BASED TUMOR REGISTRY (2009) (1)
- MP45-06 ULTRASOUND CORRELATES HIGHLY WITH CROSS SECTIONAL IMAGING FOR SMALL RENAL MASSES IN A CONTEMPORARY COHORT: RESULTS FROM THE CANADIAN KIDNEY CANCER COLLABORATION (2021) (1)
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (1)
- 20 Creation of the Toronto Biopsy Avoidance Tools (T-BAT) with clinical parameter-only and adipokine biomarker-augmented versions (2015) (1)
- 962: Expanding the Indications for Laparoscopic Radical Nephrectomy: Intermediate Oncologic Outcomes (2005) (1)
- Choosing Wisely Canada: It's our turn. (2014) (1)
- 1092 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance (2012) (1)
- Free PSA Ratio as a Predictor of Adverse Outcomes after Curative-Intent External Beam Radiation Therapy for Prostate Cancer: A Novel Application of an "Old" Biomarker (2018) (1)
- Does gender influence morbidity or mortality in the surgical treatment of renal masses? (2014) (1)
- Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes (2020) (1)
- Targeting heat-shock protein 27 enhances sensitivity to sorafenib treatment in renal cancer in vitro and in vivo (2017) (1)
- Needs Assessment Survey for the Management of Kidney Cancer (2017) (1)
- Canadian Urological Association guideline: Management of small renal masses - Summary of recommendations. (2022) (1)
- 160 Canadian TrueNTH Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients: Results of a Feasibility Study (2020) (1)
- Ultrasound Correlates Highly with Cross Sectional Imaging for Small Renal Masses in a Contemporary Cohort. (2022) (1)
- 588 Initial results of MR guided laser focal therapy for prostate cancer (2013) (1)
- Patterns of treatment toxicity in frail older men with metastatic prostate cancer (2021) (1)
- 765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER (2011) (1)
- MP16-10 EXPLORING THE VALUE OF USING PATIENT-ORIENTED MRI REPORTS IN CLINICAL PRACTICE (2021) (1)
- 320 Prostate Cancer Rehabilitation: Outcomes of a Sexual Health Clinic (2018) (1)
- 1922 COMPARISON OF RISK CALCULATORS FROM THE PROSTATE CANCER PREVENTION TRIAL AND THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER IN A CONTEMPORARY CANADIAN COHORT (2011) (1)
- Causal mediation analysis decomposition of between-hospital variance (2020) (1)
- Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care. (2020) (1)
- Tissue-Based Immunohistochemical Markers for Diagnosis and Classification of Renal Cell Carcinoma (2020) (1)
- Case - Foamy, high-grade prostatic intraepithelial neoplasia: A false positive for prostate cancer on multiparametric magnetic resonance imaging? (2018) (1)
- 82: Laparoscopic Management of Diseases of the Horseshoe Kidney (2006) (1)
- Diminished efficacy of bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer (2011) (1)
- The impact of renal cell carcinoma histopathological subtype on disease prognosis: A Canadian multi-institutional analysis. (2015) (1)
- Chemoprevention of prostate cancer: is there evidence from clinical trials? (2011) (1)
- Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake. (2022) (1)
- 1652: The Effect of Health Care Provider Characteristics on Nodal Yield at Radical Cystectomy (2007) (1)
- PD19-07 PROSTATE BIOPSY TRENDS IN RELATION TO U.S. PREVENTATIVE TASK FORCE RECOMMENDATIONS AGAINST ROUTINE PSA-BASED SCREENING: A TIME-SERIES ANALYSIS (2014) (1)
- V1152: Ureteral Tissue Balloon Expansion for Laparoscopic Bladder Augmentation: Clinical Experience (2005) (1)
- MP48-15 DOES PARTIAL NEPHRECTOMY FOR BIOPSY PROVEN FUHRMAN GRADE 3/4 RENAL CELL CARCINOMA CONFER WORSE OUTCOMES COMPARED TO RADICAL NEPHRECTOMY? RESULTS FROM A CANADIAN MUTLICENTER COHORT (2018) (1)
- Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening: Against increasing PSA threshold to 10 ng/ml. (2020) (1)
- Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system. (2020) (1)
- 1122 Prevalence of prostate carcinoma and its precursor lesions in Russian Caucasian and Japanese men in autopsy specimens: A prospective comparative international study with central pathology review (2012) (1)
- A Practical Review of the Diagnosis and Management of Small Renal Masses (2012) (1)
- MP73-02 PATIENT UNDERSTANDING REGARDING END-OF-LIFE PROSTATE CANCER AND PERSPECTIVES REGARDING COST/BENEFIT OF CURRENT TREATMENT PARADIGMS (2015) (1)
- MP53-06 MAGNETIC RESONANCE IMAGING DETECTED PROSTATE EVASIVE ANTERIOR TUMORS: FURTHER INSIGHTS (2014) (1)
- S110– How can we improve guideline implementation? Development and evaluation of self-audit tools (2010) (1)
- TREATMENT TRENDS FOR RENAL CELL CARCINOMA IN A POPULATION-BASED TUMOR REGISTRY: THE POTENTIAL UNDERUSE OF PARTIAL NEPHRECTOMY (2009) (1)
- 341 IMPACT OF METABOLIC SYNDROME ON THE RISK OF PROSTATE CANCER AND HIGH GRADE DISEASE AMONG MEN PRESENTING FOR PROSTATE BIOPSY (2013) (1)
- Contemporary outcomes of pT3 renal cell carcinoma: A Canadian multi-institutional experience. (2014) (1)
- MP42-06 THE UPTAKE OF ACTIVE SURVEILLANCE IN PROSTATE CANCER: RESULTS OF A POPULATION BASED-STUDY (2015) (1)
- MP62-08 PATIENTS THAT DEMONSTRATE GLEASON 6 VOLUME PROGRESSION ON ACTIVE SURVEILLANCE HAVE A SUBSTANTIALLY GREATER RISK OF GRADE PROGRESSION ON FURTHER FOLLOW-UP (2014) (1)
- V335: Implications of Real-Time Transrectal Ultrasound Monitoring During Nerve-Sparing Laparoscopic Radical Prostatectomy: Video (2005) (1)
- Comparison of patients with high-risk nonmetastatic clear cell renal carcinoma in adjuvant therapy trials versus nonclinical trial patients. (2022) (1)
- 886 Partial nephrectomy for the treatment of renal cell carcinoma and the risk of end stage renal disease (2013) (1)
- Daily symptom monitoring commonly leads to treatment modification in older adults receiving treatment for metastatic prostate cancer (mPC). (2022) (1)
- Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer (2021) (1)
- Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer (2015) (1)
- Salvage lymph node dissection for prostate-specific membrane antigen (PSMA) positron emission tomography (PET)-identified oligometastatic disease. (2021) (1)
- MP64-06 RECURRENCE AND SURVIVAL AFTER PARTIAL VERSUS RADICAL NEPHRECTOMY FOR T1 RENAL MASS (2014) (1)
- Oncology : Adrenal / Renal / Upper Tract / Bladder Contemporary Results of Percutaneous Biopsy of 100 Small Renal Masses : A Single Center Experience (2008) (1)
- 715 A PROSPECTIVE TRIAL OF THE ROLE OF MAGNETIC RESONANCE IMAGING FINDINGS AS A MARKER FOR MEN AT RISK OF PROSTATE CANCER PROGRESSION WITH LOW RISK DISEASE OTHERWISE SUITABLE FOR ACTIVE SURVEILLANCE (2010) (1)
- Patterns of prostate cancer management across Canadian prostate cancer treatment specialists. (2018) (1)
- A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System (2022) (1)
- A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity. (2020) (1)
- PROSTATE SPECIFIC ANTIGEN LEVEL IS A PREDICTOR OF CANCER AMONG MEN WITH HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA BUT NOT AMONG MEN WITH ATYPICAL SMALL ACINAR PROLIFERATION (2008) (1)
- 835: Laparoscopic Partial Nephrectomy: Trends Assessment in Tumor Selection and Outcomes in 300 Cases (2005) (1)
- Parenchymal-Sparing Surgery for Renal Lesions: Open versus Laparoscopic/Robotic Surgery (2009) (1)
- 52 DOES IPSILATERAL ADRENALECTOMY AT THE TIME OF RADICAL NEPHRECTOMY IMPACT OVERALL SURVIVAL (2012) (1)
- MP15-01 DEVELOPING THE BLADDER UTILITY SYMPTOM SCALE: A MULTIATTRIBUTE HEALTH STATE CLASSIFICATION FOR BLADDER CANCER (2014) (1)
- Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment (2021) (1)
- Active Surveillance Discussion for Low-risk Prostate Cancer: Patients' Preferences and Counseling Techniques. (2017) (1)
- MP86-16 FATE OF PROSTATE CANCER ANTIGEN 3 (PCA3) LEVELS MORE THAN 100: DOES INFLAMMATION PLAY A ROLE?? (2015) (1)
- [Solitary gastric plasmacytoma. Case report and review of the literature]. (1994) (1)
- Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis (2021) (1)
- Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes from the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort. (2021) (1)
- MP48-13 A NOVEL PREDICTOR OF CLINICAL PROGRESSION IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2019) (0)
- 1182 GROWTH KINETICS OF SMALL RENAL MASSES: A PROSPECTIVE ANALYSIS FROM THE RENAL CELL CARCINOMA CONSORTIUM OF CANADA (2013) (0)
- 929 The role for needle biopsy in treatment decision making for T1a renal tumors: The Toronto experience (2012) (0)
- MP66-10 HOSPITAL-LEVEL QUALITY INDICATORS FOR KIDNEY CANCER SURGERY: A VETERAN’S AFFAIR NATIONAL HEALTH SYSTEM VALIDATION OF CONCEPT (2020) (0)
- MP12-13 RENAL ANGIOMYOLIPOMA – A LARGE SINGLE-CENTER STUDY OF ITS NATURAL HISTORY (2014) (0)
- Improving outcomes through the development of quality indicators in renal cell cancer. (2012) (0)
- THE USE OF MRI IN THE DIAGNOSIS AND FOLLOW UP OF PEDIATRIC GENITOURINARY RHABDOMYOSARCOMA (1999) (0)
- Does Patient Age Impact Survival after Radical Cystectomy? (2011) (0)
- S100A11 is a potential prognostic marker for clear cell renal cell carcinoma (2015) (0)
- OP3-09 a LARGE SINGLE CENTER STUDY DESCRIBING THE EVOLUTION OF RENAL TUMOR BIOPSY (N=519; 2001-2013) (2014) (0)
- The Impact of Histopathological Subtypes on Clinical Outcomes for Surgically Treated Renal Cell Carcinoma: A Canadian Multi- Institutional Analysis (2014) (0)
- A retrospective observational study assessing bone metastases (mets) detection and management of patients (pts) with castration-resistant prostate cancer (CRPC) in Canada. (2019) (0)
- PD62-04 LONG-TERM ONCOLOGICAL OUTCOMES FOLLOWING ACTIVE SURVEILLANCE OF LOW RISK PROSTATE CANCER (2020) (0)
- Health-related quality of life in robotic versus open radical (2015) (0)
- Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC) (2017) (0)
- MP67-12 ANTI-ANDROGENS AND CABAZITAXEL IN DEFINING COMPLETE RESPONSE IN PROSTATECTOMY (ACDC TRIAL) (ACDC-RP) (2020) (0)
- 549 EXTERNAL DIAGNOSTIC PROSTATE BIOPSY IN ACTIVE SURVEILLANCE: A PREDICTOR OF RE-CLASSIFICATION ON CONFIRMATORY BIOPSY (2013) (0)
- MP57-02 THE ASSOCIATION BETWEEN PHYSICIAN TRUST AND PROSTATE SPECIFIC ANTIGEN SCREENING: IMPLICATIONS FOR SHARED DECISION MAKING (2018) (0)
- MP61-02 DEVELOPMENT, MULTI-INSTITUTIONAL EXTERNAL VALIDATION, AND ALGORITHMIC AUDIT OF SEPERA - AN ARTIFICIAL INTELLIGENCE-BASED SIDE-SPECIFIC EXTRA-PROSTATIC EXTENSION RISK ASSESSMENT TOOL FOR PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2023) (0)
- A non-invasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade (2019) (0)
- PD12-07 PREDICTORS OF PATHOLOGICALLY NODE POSITIVE DISEASE IN PATIENTS UNDERGOING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR RENAL CELL CARCINOMA (RCC): RESULTS FROM THE CANADIAN KIDNEY CANCER COLLABORATION (2018) (0)
- MP43-17 DIFFERENCES IN GLEASON SCORE (GS) DISTRIBUTION AND TUMOR AGGRESSIVENESS IN LARGE COHORTS OF ASIAN AND CAUCASIAN MEN (2021) (0)
- Associations Between Physical Activity, Quality Of Life And Emotional Well-being During Active Surveillance For Prostate Cancer (2020) (0)
- Genetic risk assessment for hereditary RCC: Report from the consensus panel meeting. (2020) (0)
- Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine (2016) (0)
- Management of Small Renal Masses (2018) (0)
- Abstract B49: Development and characterization of a novel CA9 targeting dual-antibody T-cell engager for renal cell carcinoma (2020) (0)
- MP15-12 DOES PERINEURAL INVASION ON INITIAL PROSTATE BIOPSY PREDICT HIGHER RISK OF PROGRESSION IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER? (2016) (0)
- Northeastern Section of the AUA 72nd Annual Meeting Abstracts (2020) (0)
- Multi-parametric MRI-targeted biopsy compared to systematic TRUS biopsy for biopsy-naïve men at risk for prostate cancer: 2 year follow up data and economic analysis (2023) (0)
- PD37-04 A PHASE II, RANDOMIZED, OPEN LABEL STUDY OF NEOADJUVANT DEGARELIX VERSUS LHRH AGONIST IN PROSTATE CANCER PATIENTS PRIOR TO RADICAL PROSTATECTOMY (2016) (0)
- 048 Canadian TrueNTH Sexual Health and Rehabilitation eClinic (SHAReClinic): Online Education and Support for Prostate Cancer Patients and their Partners (2019) (0)
- V1978: Real-Time Transrectal Ultrasound Guidance During Laparoscopic Radical Prostatectomy (2004) (0)
- 489: Clinical Preditors of Gleason Score Upgrading: Implications for Patients Considering Watchful Waiting or Brachytherapy (2006) (0)
- 158 PREVALENCE OF PROSTATE CARCINOMA AND ITS PRECURSOR LESIONS IN RUSSIAN CAUCASIAN AND JAPANESE MEN IN AUTOPSY SPECIMENS (2012) (0)
- 878: Laparoscopic Partial Nephrectomy for >=PT2 Tumors (2006) (0)
- V1592: Contemporary Technique for Laparoscopic Partial Nephrectomy (2005) (0)
- 1250 THE ROLE OF DUTASTERIDE IN PREVENTING BPH CLINICAL PROGRESSION IN ASYMPTOMATIC MEN WITH AN ENLARGED PROSTATE (2012) (0)
- 1837 EXTERNAL VALIDATION OF THE PROSTATE CANCER PREVENTION TRIAL RISK CALCULATOR IN A CANADIAN COHORT (2010) (0)
- 319 Renal angiomyolipomas – a study of their natural history (2014) (0)
- A phase I pilot study of preoperative radiotherapy for prostate cancer: Long-term toxicity and oncologic outcomes. (2019) (0)
- MEDICATION USE AND KIDNEY CANCER RISK: A POPULATION‐BASED STUDY: PD52‐07 (2017) (0)
- MP50-13 CAN ONCOCYTOMAS BE SAFELY MONITORED BY SURVEILLANCE? (2015) (0)
- ASSOCIATION BETWEEN GERMLINE GENETIC VARIATION AND PROGRESSION IN MEN WITH LOW‐RISK PROSTATE CANCER ON ACTIVE SURVEILLANCE: PD28‐01 (2017) (0)
- THE IMPACT OF QUALITY VARIATION ON PATIENTS UNDERGOING SURGERY FOR RENAL CELL CARCINOMA: A NATIONAL CANCER DATABASE STUDY: MP22‐06 (2017) (0)
- Preliminary results of a two stage phase II study of 18F-DCFPyL PET-MR for enabling oligometastases ablative therapy in subclinical prostate cancer. (2019) (0)
- The Role of Renal Biopsy (2018) (0)
- 1469 T1G3 BLADDER CANCER TREATED CONSERVATIVELY WITH BCG OR WITH NO BCG: LONG -TERM FOLLOW UP IN 249 PATIENTS (2010) (0)
- 1605 RISK FACTORS FOR UPPER URINARY TRACT AND URETHRAL RECURRENCES AFTER RADICAL CYSTECTOMY (2011) (0)
- Statin use and time to progression in men on active surveillance for prostate cancer (2018) (0)
- Moving beyond PSA: Identifying the optimal diagnostic strategy to assess prostate cancer risk (2022) (0)
- Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes. (2022) (0)
- 643: Intermediate and Long Term Oncologic Outcomes after Laparoscopic Radical Nephrectomy for Locally Advanced (PT2-PT4) Renal Cell Carcinoma (2007) (0)
- 1401 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER (2011) (0)
- V490: Vesicovaginal Fistula Repair. Our Laparoscopic Technique (2005) (0)
- Prostate cancer quality of care disparities and their impact on patient outcomes (2018) (0)
- PD46-01 IMPACT OF TIME-TO-SURGERY AND SURGICAL DELAY ON ONCOLOGIC OUTCOMES FOR RENAL CELL CARCINOMA (2019) (0)
- Draft Guideline 27-3 A Quality Initiative of the Program in Evidence-Based Care ( PEBC ) , Cancer Care Ontario ( CCO ) Magnetic Resonance Imaging for Pre-Treatment Local Staging of Prostate Cancer (2016) (0)
- Preoperative brimonidine tartrate 0.2% effect on intraocular pressure of patients undergoing robot-assisted radical laparoscopic prostatectomy in steep Trendelenburg position (2017) (0)
- 625 A non-invasive urine-based epigenetic urinary biomarker panel for the detection of bladder cancer and the discrimination of high-grade and low-grade disease (2014) (0)
- MP28-04 DO HIGH-VOLUME RENAL TUMOR BIOPSY CENTERS HAVE LOWER RATES OF BENIGN HISTOLOGY FOLLOWING NEPHRECTOMY FOR SMALL RENAL MASSES? (2018) (0)
- Reply by Authors. (2022) (0)
- Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (0)
- Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue (2022) (0)
- 84 LEAN TECHNOLOGY IMPROVES EFFICIENCY IN OUTPATIENT ACADEMIC URO-ONCOLOGY CLINICS (2011) (0)
- MP41-03 IS A RENAL TUMOUR BENIGN OR MALIGNANT? A PREDICTION TOOL INCLUDING PATIENTS MANAGED WITH SURGERY, ABLATION, OR SURVEILLANCE (2023) (0)
- MP67-16 DETERMINING THE BEST COMPLETE BLOOD COUNT-BASED BIOMARKER FOR ONCOLOGIC OUTCOMES FOLLOWING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER (2015) (0)
- MP23-18 FACTORS ASSOCIATED WITH LONG-TERM ADHERENCE TO ACTIVE SURVEILLANCE AMONG MEN WITH LOW RISK PROSTATE CANCER: A POPULATION BASED STUDY FROM ONTARIO (2020) (0)
- Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation. (2022) (0)
- PD41-09 MOVING BEYOND PSA: IDENTIFYING THE OPTIMAL DIAGNOSTIC STRATEGY TO ASSESS PROSTATE CANCER RISK (2022) (0)
- Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions. (2023) (0)
- Assessing the effects of radiation on the small bowel. (2013) (0)
- PD03-04 LONG-TERM ONCOLOGIC OUTCOMES OF RADICAL PROSTATECTOMY IN A LARGE COHORT OF PATIENTS ON ACTIVE SURVEILLANCE (2016) (0)
- Appendix for: The uptake of active surveillance for the management of prostate cancer: A population-based analysis (2016) (0)
- A Prospective Provincial PSMA-PET Registry for Recurrent Prostate Cancer: Preliminary results (2020) (0)
- CYSTIC RENAL MASSES: IS THE BOSNIAK CLASSIFICATION SYSTEM AN ADEQUATE PREDICTOR OF SURVIVAL?: PD11‐06 (2017) (0)
- 346 DO ASIAN AND CAUCASIAN MEN DEVELOP HIGH GRADE (GLEASON &[GE]7) PROSTATE CANCER AT THE SAME AGE? AN AUTOPSY STUDY (2013) (0)
- WHAT FALSE NEGATIVE RATE OF NON‐INVASIVE TESTING ARE ACTIVE SURVEILLANCE PATIENTS AND URO‐ONCOLOGISTS WILLING TO ACCEPT IN ORDER TO AVOID PROSTATE BIOPSY?: MP77‐18 (2017) (0)
- 554 Upstaging of urothelial cancer at the time of radical cystectomy – associated factors and effect on outcome (2012) (0)
- 1498 ACTIVE SURVEILLANCE PROSTATE RE-BIOPSY SCHEMA: RESULTS OF ROUTINE TRANSITION ZONE BIOPSIES (2013) (0)
- Reply by Authors. (2020) (0)
- Laparoscopic access and exit (2008) (0)
- MP06-18 PREDICTING PERIOPERATIVE COMPLICATIONS IN PATIENTS RECEIVING RADICAL CYSTECTOMY USING PRE-OPERATIVE CT-MEASURED ADIPOSE TISSUE INDICES (2018) (0)
- 154 COULD SCREENING FOR BLADDER CANCER PRODUCE A STAGE MIGRATION TOWARDS DETECTION OF NON-MUSCLE-INVASIVE CANCERS? (2011) (0)
- MP57-18 SHORT-TERM OUTCOME OF METASTASECTOMY IN RENAL CELL CARCINOMA: THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM INITIAL EXPERIENCE. (2014) (0)
- V1157: Vascular Complications in Laparoscopic Urologic Procedures (2005) (0)
- 2235 SERUM ADIPOKINE LEVELS IMPROVE PROSTATE CANCER PREDICTION COMPARED TO CLINICAL DATA ONLY (2012) (0)
- 755 A five-gene DNA-methylation biomarker panel sensitively detects bladder cancer and discriminates between high-grade and low-grade disease in voided urine (2015) (0)
- LBA-15 RENAL HYPOTHERMIA DURING PARTIAL NEPHRECTOMY: A RANDOMIZED CONTROLLED TRIAL (2019) (0)
- V1586: Hydro-Jet Assisted Laparoscopic Partial Nephrectomy in the Calf Model (2005) (0)
- IDENTIFYING BARRIERS TO THE ADOPTION OF PERCUTANEOUS RENAL TUMOUR BIOPSY IN THE MANAGEMENT OF SMALL RENAL MASSES: MP67‐20 (2017) (0)
- Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer : A Cancer Care Ontario clinical practice guideline CCO guidelines (2016) (0)
- 87: Renal Artery Pseudoaneurysm Following Laparoscopic Partial Nephrectomy (2005) (0)
- Abstract No. 330: Histological concordance between repeat renal mass biopsies and between biopsy and nephrectomy specimens (2010) (0)
- 1330 IS PERINEURAL INVASION IN PROSTATE BIOPSIES ASSOCIATED WITH ADVERSE PATHOLOGICAL OUTCOME? OLD PARADIGM REVISITED (2012) (0)
- Patient trust in cancer information from physician The association between physician trust and prostate-specific antigen screening : Implications for shared decision-making (2018) (0)
- MP59-16 RENAL ARTERY PSEUDOANEURYSMS AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: INCIDENCE, MANAGEMENT AND FUNCTIONAL OUTCOMES FROM CANADIAN KIDNEY CANCER INFORMATION SYSTEM DATABASE. (2014) (0)
- Prise en charge du cancer du rein : Forum canadien sur le cancer du reinà jour de 2011 du consensus (2012) (0)
- Real World Practice Patterns and Predictors of Continuous versus Intermittent ADT Use for Prostate Cancer in Older Men. (2021) (0)
- Magnetic Resonance Imaging for Pre-Treatment Local Staging of Prostate Cancer (2020) (0)
- Use of a surgically derived nomogram to predict high likelihood of Gleason score upgrading for favorable-risk prostate cancer treated with permanent seed brachytherapy. (2011) (0)
- MP 101 Convective water vapor thermal therapy : 3-year durable outcomes of a randomized controlled study for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (2018) (0)
- Reply by Authors. (2021) (0)
- Detection of novel variant TMPRSS2 /ERG fusion transcripts suggests independent genomic alterations may underlie origin of multi-centric prostate cancer. (2006) (0)
- Hospital-level quality indicators for kidney cancer surgery: A Veteran’s Affairs national health system validation of concept. (2020) (0)
- Quality of active surveillance (AS) care received by an aging population in low risk prostate cancer: Applying quality indicators to understand quality of care at the population level (2021) (0)
- Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach (2022) (0)
- Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer (2020) (0)
- Comparison of outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide: A population-based study (2020) (0)
- MP-01 . 02 Comparative Effectiveness of Robotic-assisted and Open Radical Prostatectomy in the “ Post-Learning Curve ” (2014) (0)
- Editorial Comment. (2017) (0)
- 56: Probe Ablative Therapy for Small Tumors in a Solitary Kidney: Experience in 36 Patients (2005) (0)
- 1952: Impact of Extended Prostate Biopsy on Minimization of the Volume-Grade Bias in Prostate Cancer Detection (2007) (0)
- Treating small renal masses: Costing it out. (2013) (0)
- PD18-07 A NON-INVASIVE URINE-BASED METHYLATION BIOMARKER PANEL FOR BLADDER CANCER DETECTION (2019) (0)
- Erratum to "The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System" [Urol Oncol 34(11) (2016) 486.e1-486.e7]. (2017) (0)
- 1292 PROSTATE MRI FINDINGS PRIOR TO COMMENCING ACTIVE SURVEILLANCE AMONG MEN WITH LOW RISK PROSTATE CANCER (2011) (0)
- Cost-Effectiveness Analysis of Negative Pressure Wound Therapy to Prevent Surgical Site Infection After Elective Colorectal Surgery (2021) (0)
- MP14-13 PRIORITIZATION OF RENAL CANCER QUALITY INDICATORS USING VARIANCE DECOMPOSITION AND MEDIATION ANALYSIS METHODS (2019) (0)
- Quality of care during active surveillance in low-risk prostate cancer patients: A population-based approach. (2018) (0)
- International Multicenter Validation of an Intermediate-Risk Subclassification of Men Treated with Radical Treatment Without Hormone Therapy (2018) (0)
- MP34-15 PROSTATE CANCER QUALITY OF CARE DISPARITIES AND THEIR IMPACT ON PATIENT OUTCOMES (2018) (0)
- 464 RENAL CELL CARCINOMA IN NATIVE KIDNEYS IN A RENAL TRANSPLANT POPULATION (2010) (0)
- 2219 DOES THE ADDITION OF APICAL INJECTION OF LOCAL ANESTHESIA TO BASAL INJECTION DIMINISH PAIN RELATED TO TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY (2012) (0)
- THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER (2011) (0)
- 62: A Prospective Provincial Psma-Pet Registry for Recurrent Prostate Cancer: Preliminary Results (2020) (0)
- Reply By Authors. (2020) (0)
- MP15-08 QUALITY OF LIFE FOLLOWING FOCAL THERAPY, ACTIVE SURVEILLANCE AND ROBOTIC PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER (2014) (0)
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (0)
- 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY (2012) (0)
- CO107 Clinical Outcomes of Patients With Metastatic Renal Cell Carcinoma (MRCC) With or Without Sarcomatoid Differentiation Treated With Systemic Therapy in Real-World Canadian Setting (2022) (0)
- 504 PATHOLOGIC OUTCOMES OF RADICAL PROSTATECTOMY FOLLOWING ACTIVE SURVEILLANCE (2012) (0)
- MP-07 . 01 Rapid prediction of personalized response to chemotherapy using submillimeter ex-vivo biopsy samples on chip (2016) (0)
- MP64-03 LOW METASTATIC POTENTIAL OF COMPLEX RENAL CYSTS: THE Case FOR ACTIVE SURVEILLANCE (2023) (0)
- 662 THE SIGNIFICANCE OF FINDING NO PROSTATE CANCER ON THE ACTIVE SURVEILLANCE CONFIRMATORY BIOPSY: IMPLICATIONS FOR PATHOLOGICAL RE-CLASSIFICATION (2013) (0)
- Urological Oncology: Adrenal, Renal, Ureteral and Retroperitoneal Tumors (2013) (0)
- MP14-01 NATURAL HISTORY OF RENAL ANGIOMYOLIPOMA (AML) FAVORS SURVEILLANCE AS AN INITIAL APPROACH (2019) (0)
- WHAT FALSE‐NEGATIVE RATES ARE BLADDER CANCER PATIENTS AND URO‐ONCOLOGISTS WILLING TO ACCEPT IN ORDER TO AVOID SURVEILLANCE CYSTOSCOPY?: PD19‐11 (2017) (0)
- LAPAROSCOPIC REPAIR OF RECTOURETHRAL FISTULAE (2006) (0)
- Long-term oncological outcomes following active surveillance of low risk prostate cancer: A population-based study (2020) (0)
- 347 PREVALENCE OF INFLAMMATION AND PROSTATE CARCINOMA IN ASIAN AND CAUCASIAN MEN: AN AUTOPSY STUDY (2013) (0)
- A Novel Metric for Hospital Quality in Kidney Cancer Surgery: A Veterans Affairs National Health System Validation of Concept (2021) (0)
- MP76-13 CANADIAN CONSENSUS GUIDELINES FOR SEXUAL REHABILITATION FOLLOWING PROSTATE CANCER TREATMENT (2016) (0)
- Differences in contemporary biopsy Gleason score distribution in men diagnosed with prostate cancer from China and Canada (2019) (0)
- 883 International urology journal club via twitter – twelve month experience (2014) (0)
- 1290 DOES SURGEON AND HOSPITAL VOLUME AFFECT OUTCOMES FOR SURGERY FOR RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA INVOLVEMENT? – RESULTS OF A NATIONAL POPULATION BASED STUDY (2012) (0)
- MP73-11 A COMPREHENSIVE COMPETING RISK CALCULATOR FOR PATIENTS WITH CORTICAL RENAL MASSES < 10CM: A NOVEL CLINICAL DECISION AID FOR SHARED DECISION-MAKING REGARDING INDIVIDUALIZED TREATMENT SELECTION (2016) (0)
- PD41-03 VALIDATED HOSPITAL QUALITY METRICS FOR RADICAL CYSTECTOMY: DISEASE-SPECIFIC AND CORRELATED TO LONG-TERM OUTCOMES (2018) (0)
- Canadian consensus forum of key controversial areas in the management of advanced prostate cancer (2021) (0)
- Genomic characterization of non-schistosomiasis-related squamous cell carcinoma (NSR-SCC) of the urinary bladder: A retrospective study of potential prognostic and predictive biomarkers (2019) (0)
- PSA VELOCITY IN MEN STARTING 5‐ALPHA‐REDUCTASE INHIBITORS AT THE TIME OF STARTING ACTIVE SURVEILLANCE IS A PREDICTOR OF PATHOLOGICAL PROGRESSION IN LOW‐RISK PROSTATE CANCER: PD55‐06 (2017) (0)
- The uptake of active surveillance for the management of prostate cancer: A population-based analysis. (2016) (0)
- MP14-04 OUTCOMES OF RADIATION FOLLOWING EXPECTANT MANAGEMENT FOR LOW RISK, LOCALIZED PROSTATE CANCER (2016) (0)
- MP50-05 HOW WELL DOES RENAL MASS SIZE MEASURED BY ULTRASOUND CORRELATE WITH MEASUREMENTS OBTAINED BY CT, MRI OR PATHOLOGY? ANALYSIS FROM THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM (2020) (0)
- MP84-08 PATHOLOGICAL UPSTAGING OF CLINICAL T1 RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS OF OUTCOMES (2015) (0)
- V687: Laparoscopic Extended Pelvic Lymphadenectomy for Bladder Cancer: The Technique (2004) (0)
- PD58-06 INCORPORATING MEASURES OF PATIENT SAFETY INTO TECHNICAL SKILL ASSESSMENTS IN ROBOTIC ASSISTED RADICAL PROSTATECTOMY (2018) (0)
- Surgically-derived Nomogram Predicts High Likelihood of Gleason Score Upgrading for Favorable Risk Prostate Cancer Treated With Permanent Seed Brachytherapy (2011) (0)
- PD41-08 CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE AFTER RADICAL OR PARTIAL NEPHRECTOMY FOR T1A RENAL CELL CARCINOMA: A POPULATION-BASED STUDY (2019) (0)
- 270 The significance of finding no prostate cancer on the active surveillance confirmatory biopsy: Implications for pathological re-classification (2013) (0)
- CUAJ – Original Research Timilshina et al Quality indicators for level of care during AS in PCa (2021) (0)
- 1677 NATURAL HISTORY OF RENAL FUNCTION IN UNTREATED KIDNEY CANCER (2012) (0)
- The association between physician trust and prostate specific antigen screening: Implications for shared decision making (2018) (0)
- Real-world management of advanced prostate cancer: A Canadian comparison of academic specialists and community-based prostate cancer physicians. (2020) (0)
- Preliminary Results of a Two Stage Phase II Study of 18F-DCFPyL PET-MR for Enabling Oligometastases Ablative Therapy in Subclinical Prostate Cancer (2019) (0)
- Urological Association recommendations on prostate cancer screening and early diagnosis (2017) (0)
- MP13-02 IS RE-RESECTION NECESSARY? RE-RESECTION OF NON-MUSCLE INVASIVE BLADDER CANCER AT A TERTIARY CARE CENTER (2016) (0)
- MP79-10 THE ROLE OF PROSTATE CANCER ANTIGEN 3 TEST AND MULTI-PARAMETRIC PROSTATIC MAGNETIC RESONANCE IMAGING FOR DIAGNOSIS OF PROSTATE CANCER IN PATIENT WITH MULTIPLE PRIOR NEGATIVE BIOPSIES (2014) (0)
- CO177 Association Between the Sarcomatoid Status and Percentage of Sarcomatoid on the Clinical Outcomes of Localized Renal Cell Carcinoma Post Nephrectomy (2022) (0)
- 424 A POPULATION-BASED STUDY OF SURGEON CHARACTERISTICS ASSOCIATED WITH THE UPTAKE OF CONTEMPORARY TECHNIQUES IN RENAL SURGERY (2012) (0)
- Cystoscopic surveillance protocol for ureteral stents used to manage malignant ureteral obstruction: reducing morbidity of frequent stent changes. (2022) (0)
- Oncologic outcomes of radiation therapy following active surveillance for low- and intermediate-risk localized prostate cancer. (2017) (0)
- A Matched Analysis of Active Surveillance Versus Nephrectomy for T1a Small Renal Masses. (2023) (0)
- Reply by the Authors. (2020) (0)
- Perspectives of prostate cancer patients about active surveillance. (2018) (0)
- 306 The natural evolution of oncocytomas: Can they be safely followed by surveillance? (2015) (0)
- POSITIVE SURGICAL MARGINS IN PARTIAL NEPHRECTOMY DO NOT IMPACT INTERMEDIATE-TERM SURVIVAL: A POPULATION BASED STUDY (2009) (0)
- 890 Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men (2014) (0)
- Surgically-Derived Nomogram Predicts High Likelihood of Gleason Score Upgrading for Favorable Risk Prostate Cancer Treated With Permanent Seed Brachytherapy at Princess Margaret Hospital (2011) (0)
- 466 SALVAGE RADICAL PROSTATECTOMY IN MEN FOLLOWING HIGH-INTENSITY FOCUSED ULTRASOUND FOR PROSTATE CANCER (2010) (0)
- Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (0)
- Prostate cancer detection after negative biopsy: MRI, biomarker or systematic biopsy (2020) (0)
- 4: Caro Acura 2016 Primary Analysis of a Phase II Study of Metastasis-Directed Ablative Therapy to Psma (18F-DCFPYL) Pet-Mr/ Ct Defined Oligorecurrent Prostate Cancer (2020) (0)
- MP64-18 CHEMOPREVENTION IN KIDNEY CANCER: SURVIVAL OUTCOMES IN DIABETICS (2016) (0)
- 2022 WUOF/SIU International Consultation on Urological Diseases: Active Surveillance for Small Renal Masses (2022) (0)
- SAFETY AND FEASIBILITY OF REAL‐TIME MRI‐GUIDED FOCUSED ULTRASOUND FOR FOCAL THERAPY OF LOCALIZED PROSTATE CANCER USING THE EXABLATE 2100 DEVICE: PHASE 1 STUDY: MP70‐16 (2017) (0)
- PD07-10 OUTCOMES OF PARTIAL NEPHRECTOMY FOR NON-METASTATIC cT2 RENAL TUMORS: RESULTS FROM A CANADIAN MULTI-INSTITUTIONAL COLLABORATIVE (2022) (0)
- Feasibility and acceptability of remote symptom monitoring (RSM) in older adults during treatment for metastatic prostate cancer. (2023) (0)
- MP44-12 mpMRI-TARGETED BIOPSY COMPARED TO SYSTEMATIC TRUS BIOPSY FOR MEN AT RISK FOR PROSTATE CANCER: 2 YEAR FOLLOW UP DATA AND ECONOMIC ANALYSIS (2023) (0)
- 464 CONSISTENCY OF TUMOR POSITION ON REPEAT PROSTATE BIOPSY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER-IMPLICATIONS FOR HEMIABLATION (2011) (0)
- PD47-10 IMPACT OF METABOLIC SYNDROME ON STAGE, GRADE AND OVERALL FAILURE IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER (2015) (0)
- V336: Laparoscopic Radical Prostatectomy: A Novel Technique of Lateral Pedicle Control and Nerve Preservation (2005) (0)
- The Relationship Between Preoperative Physical Activity With American Society of Anesthesiologists Score and Postoperative Length of Stay in Patients Undergoing Radical Prostatectomy. (2021) (0)
- Surgical ischemia and detection of clear cell renal cell carcinoma biomarkers. (2014) (0)
- MP48-08 THE LONG-TERM OUTCOMES OF GRADE GROUPS 2 AND 3 PROSTATE CANCER MANAGED BY ACTIVE SURVEILLANCE: RESULTS FROM A LARGE POPULATION-BASED COHORT (2019) (0)
- Abstract 1278: Determining the proteomic changes that define progressor and non-progressor clear cell renal cell carcinoma (2012) (0)
- Perspectives of health care professionals on active surveillance for the management of prostate cancer. (2018) (0)
- Correction to: Exploring the value of using patient‑oriented MRI reports in clinical practice — a pilot study (2022) (0)
- DEFINING A COHORT OF MEN WHO MAY NOT REQUIRE REPEAT PROSTATE BIOPSY BASED ON PCA3 AND MRI: THE DOUBLE NEGATIVE EFFECT.: MP38‐05 (2017) (0)
- Effect of abiraterone acetate (AA) and enzalutamide (EZ) administration on chemotherapy-naïve metastatic castration-resistant prostate cancer (CN-mCRPC) patient’s symptom burden. (2016) (0)
- Improving outcomes through the development of quality indicators in renal cell cancer. (2012) (0)
- PD24-08 A RANDOMIZED CONTROLLED TRIAL OF “BAG-SQUEEZE” TO MINIMIZE DISCOMFORT IN MALE OUTPATIENT FLEXIBLE CYSTOSCOPY (2020) (0)
- Multimodal Biomarkers that Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance. (2023) (0)
- MP14-04 RENAL BIOPSY - WHEN WILL IT CHANGE MANAGEMENT? (2019) (0)
- Re: Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses? (2019) (0)
- Treatment on active surveillance of small renal masses: Progression versus anxiety (2020) (0)
- High‐dose oral vitamin D3 administration increases serum and prostate levels of vitamin D metabolites safely in prostate cancer patients (2012) (0)
- MP61-08 TOWARDS PERSONALIZED CARE OF CT1A PAPILLARY RCC DIAGNOSED ON BIOPSY (2021) (0)
- Does Post-diagnosis Physical Activity Prolong the Duration of Active Surveillance in Men With Prostate Cancer? (2019) (0)
- A phase II trial of neoadjuvant metformin in prostatic adenocarcinoma with serum and tissue biomarker evaluation. (2012) (0)
- 79 THE TRUE RISK OF BLOOD TRANSFUSION AFTER NEPHRECTOMY FOR RENAL MASSES (2012) (0)
- Laparoscopic surgery for vesicovaginal fistulas (2008) (0)
- 2202 PREDICTORS OF FAILING ACTIVE SURVEILLANCE ON THE SECOND PROSTATIC BIOPSY (2012) (0)
- 852 Prostate biopsy trends in relation to U.S. Preventative Task for recommendations against routine PSA-based screening: A time-series analysis (2014) (0)
- 1049 Surgeon-volume and outcome relation in transurethral resection of bladder tumour (TURBT) (2012) (0)
- Extended lymphadenectomy and adjuvant chemotherapy in muscle-invasive bladder cancer treated by radical cystectomy. (2012) (0)
- Preoperative trial of neoadjuvant abiraterone plus or minus cabazitaxel: Early results. (2019) (0)
- V1970: Laparoscopic Urethro-Vesical Anastomosis: Evolution of the Technique (2004) (0)
- Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy. (2014) (0)
- Preoperative sorafenib (Sor) and cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC). (2011) (0)
- Can incomplete metastasectomy impact renal cell carcinoma outcomes? A propensity score matching analysis from a prospective multicenter collaboration (2021) (0)
- 5{alpha}-reductase inhibitors and the risk of grade reclassification for men with long-term follow-up on active surveillance for prostate cancer. (2016) (0)
- 2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC). (2022) (0)
- 951 Use of initial active surveillance among men with low-risk prostate cancer (2016) (0)
- Reply by Authors. (2019) (0)
- 99 PRE-OPERATIVE SORAFENIB IN METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY (2010) (0)
- 988 Obesity associated with larger prostate volume but not with worse urinary symptoms: Analysis of a large cohort undergoing trans-rectal ultrasound (2013) (0)
- Platinum Priority – Kidney Cancer Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell – Cell Communication in Renal Cell Carcinoma (2016) (0)
- 816: Is Transperitoneal Laparoscopic Radical Prostatectomy associated with a Greater Presence of Small Bowel in the Planning Target Volume for Adjuvant or Salvage Radiotherapy? (2007) (0)
- The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making. (2018) (0)
- MP62-05 QUALITY OF CARE DURING ACTIVE SURVEILLANCE IN LOW RISK PROSTATE CANCER PATIENTS: A POPULATION-BASED APPROACH (2021) (0)
- Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC) (2019) (0)
- 311 Multicentre experience of uptake of renal tumour biopsies for small renal masses (2014) (0)
- LAPAROSCOPIC PELVIC LYMPHADENECTOMY FOR PROSTATE AND BLADDER CANCER (2006) (0)
- Guidelines on the management of cystic renal lesions – (2016) (0)
- Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis (2023) (0)
- 309 Cystic renal cell carcinoma – favourable prognosis regardless of tumour size or T-stage confirmed in large population-level study at ten years follow up (2015) (0)
- MP15-02 COMPARING RADICAL CYSTECTOMY WITH AND WITHOUT NEOADJUVANT CHEMOTHERAPY TO RADIATION THERAPY-BASED BLADDER CONSERVATION APPROACHES FOR MUSCLE-INVASIVE BLADDER CANCER: A DECISION ANALYSIS (2014) (0)
- 18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center (2021) (0)
- Embracing technology. (2007) (0)
- 2331 ASSOCIATION OF ADIPOKINES WITH PROSTATE CANCER AND HIGH GRADE DISEASE DEPENDS ON BODY MASS INDEX (2011) (0)
- 194 OUTCOME OF T1 NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) TREATED WITH BACILLUS CALMETTE-GUERIN (BCG): DIFFERENCES BETWEEN PRIMARY AND NON-PRIMARY TUMOURS (2010) (0)
- Surgeon-level versus hospital-level quality variance in kidney cancer surgery. (2023) (0)
- Cystic Renal Masses: Old and New Paradigms. (2023) (0)
- PD02-07 A NOVEL CLINICAL DECISION AID TO SUPPORT PERSONALIZED TREATMENT SELECTION FOR PATIENTS WITH RENAL CORTICAL MASSES ≤7 CM: RESULTS FROM A MULTI-INSTITUTIONAL COMPETING RISKS ANALYSIS INCLUDING PERFORMANCE STATUS AND COMORBIDITY (2020) (0)
- Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2018) (0)
- 5-Alpha-Reductase Inhibition as a Secondary Preventive Strategy (2017) (0)
- Use of Combined Hormone Therapy with Post-Operative Radiation Treatment for Prostate Cancer: Impact of Randomized Trials On Clinical Practice (2019) (0)
- MP41-05 SENSITIVITY AND SPECIFICITY OF RENAL MASS BIOPSY FOR SMALL RENAL MASSES USING REPEAT BIOPSY AS A PATHOLOGICAL SURROGATE TO NEPHRECTOMY (2023) (0)
- Extended lymphadenectomy and adjuvant chemotherapy in muscle-invasive bladder cancer treated by radical cystectomy. (2012) (0)
- MP61-18 NOVEL USE OF PREOPERATIVE STAGING CT SCAN AS A TOOL TO MEASURE VISCERAL ADIPOSE TISSUE (VAT) AS A SURROGATE FOR BODY MASS INDEX (BMI) TO CORRELATE OUTCOMES FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CANCER OF THE BLADDER. (2014) (0)
- Constructing inverse probability weights for institutional comparisons in healthcare (2020) (0)
- A High Percent-Free PSA in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated With Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank Specimens. (2020) (0)
- PD10-12 CLINICAL OUTCOMES FOLLOWING LAPAROSCOPIC MANAGEMENT OF PT3 RENAL MASSES: A MULTI-INSTITUTIONAL ANALYSIS (2014) (0)
- MP40-02 INCREASED UPTAKE OF RENAL TUMOUR BIOPSIES FOR SMALL RENAL MASSES – RESULTS OF A MULTICENTRE CANADIAN EXPERIENCE (2014) (0)
- What patient factors predict PSA testing among men aged 50 and above (2018) (0)
- V1349: Laparoscopic Nerve-Sparing Radical Cystectomy with Orthotopic Ileal Neobladder (2005) (0)
- PD48-10 PROSTATE CANCER DETECTION AFTER NEGATIVE BIOPSY (2020) (0)
- 1476 PATIENTS WITH NON PRIMARY PT1 NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC) TREATED WITH BACILLUS CALMETTE-GUERIN (BCG) ARE AT HIGHER RISK OF PROGRESSION COMPARED TO PRIMARY T1 TUMORS (2010) (0)
- PD10-07 PREDICTORS OF RADIOGRAPHIC PROGRESSION IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ABIRATERONE: RETROSPECTIVE ANALYSIS OF COU-AA-302 (2018) (0)
- CMAR_A_226174 10043..10050 (2019) (0)
- The impact of pre-cancer (Ca) diagnosis (Dx) psychiatric utilization (PU) on survival in patients with solid organ ca: A population analysis in Ontario, Canada. (2018) (0)
- Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (0)
- Optimizing the management of patients with small renal masses in a Canadian context: A Markov decision-analysis model. (2021) (0)
- Impact of multiparametric endorectal coil prostate MRI on disease reclassification among active surveillance candidates: A prospective cohort study. (2012) (0)
- Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance. (2023) (0)
- 221 OUTCOMES FOLLOWING ACTIVE SURVEILLANCE IN PROSTATE CANCER PATIENTS WITH A PSA >10 (2013) (0)
- PD17-11 POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: PREDICTORS AND IMPACT ON ONCOLOGICAL OUTCOMES (2014) (0)
- Abstract B60: Functional genomic landscape of T-cell mediated cytotoxicity (2020) (0)
- CUAJ – Original Research Nayan et al Long-term outcomes of PN vs. RN for T1a RCC (2020) (0)
- 1363 WHAT IS THE BEST TREATMENT STRATEGY FOR INCIDENTALLY DETECTED SMALL RENAL MASSES? A DECISION ANALYSIS (2010) (0)
- 1022 SURGEON-VOLUME AND OUTCOME RELATION IN TRANSURETHRAL RESECTION OF BLADDER TUMOUR (TURBT) (2010) (0)
- V493: Laparoscopic Repair of Rectourethral Fistulae (2006) (0)
- Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial (2022) (0)
- Implementing robot-assisted radical prostatectomy - one for all and all for one. (2017) (0)
- Development, multi-institutional external validation, and algorithmic audit of SEPERA – An artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy (2023) (0)
- Learning from Our Past Mistakes: A Call for Randomized Controlled Trials in Localized Renal Cell Carcinoma. (2020) (0)
- MP-06.01 Measurement of Endothelial Dysfunction via Peripheral Arterial Tonometry (PAT) Predicts Vasculogenic Erectile Dysfunction (ED) Can Predict Integrity of Pelvic Floor and Return of Erectile Function Moderated Posters 6: ED, Infertility and Transplantation June 25, 2013, 1400-1600 (2013) (0)
- MP42-01 NO SIGNIFICANT IMPROVEMENT IN PATIENT OUTCOMES WHEN STRICTER ACTIVE SURVEILLANCE CRITERIA ARE APPLIED: A COMPARISON OF CONTEMPORARY ACTIVE SURVEILLANCE PROTOCOLS (2015) (0)
- SEPERA – a novel artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy (2023) (0)
- 1862 SURGEON VOLUME-OUTCOME RELATIONSHIPS IN THE TREATMENT OF RENAL MASSES (2011) (0)
- MP74-14 EXTREMELY HIGH LEVELS OF PCA-3 IS ASSOCIATED WITH PROSTATIC INFLAMMATION (2014) (0)
- PSMA-PET/CT Registry for Recurrent Prostate Cancer (PREP): Initial findings from a single center. (2021) (0)
- MP15-06 HEALTH-RELATED QUALITY OF LIFE IN ROBOTIC VERSUS OPEN RADICAL PROSTATECTOMY: FIRST REPORT (2014) (0)
- Laparoscopic complications: reconstructive aspects (2008) (0)
- Reply by Authors. (2020) (0)
- MP59-11 CYSTIC RENAL CELL CARCINOMA PORTENDS EXCELLENT PROGNOSIS – RESULTS OF A LARGE POPULATION-LEVEL OUTCOME STUDY (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Antonio Finelli?
Antonio Finelli is affiliated with the following schools:
